Which sedative keeps the voice box nerve safer during thyroid surgery?
NCT ID NCT07195214
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 60 adults having thyroid surgery to see if the sedative dexmedetomidine or midazolam affects how well doctors can monitor a nerve that controls the voice box. The goal was to find out which drug helps surgeons identify the nerve faster and with better signal quality, which could reduce the risk of voice problems after surgery. Results will help anesthesiologists choose the best sedative for safer thyroid operations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
80 people
The number who actually took part.
- Started
-
Feb 2025
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consisted of adult patients (aged 18-65 years) scheduled for elective thyroidectomy under general anesthesia with intraoperative nerve monitoring. All participants were ASA physical status I-II, had no pre-existing laryngeal nerve dysfunction, and provided written informed consent. Patients were recruited at Amasya University Sabuncuoğlu Şerefeddin Training and Research Hospital, Department of General Surgery.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Adults aged 18-65 years Patients scheduled for elective thyroidectomy under general anesthesia American Society of Anesthesiologists (ASA) physical status I-II Planned use of intraoperative nerve monitoring (IONM) Provided written informed consent Exclusion Criteria: Previous neck surgery or radiotherapy affecting recurrent laryngeal nerve anatomy Pre-existing vocal cord paralysis or laryngeal nerve dysfunction Severe cardiovascular disease (e.g., advanced heart block, uncontrolled hypertension) Severe hepatic or renal dysfunction Known allergy or contraindication to dexmedetomidine, midazolam, or study medications Pregnancy or breastfeeding Refusal to participate or inability to provide informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Thyroid surgery intraoperative nerve monitoring (IONM) recurrent laryngeal nerve function dexmedetomidine VS midazolam (anesthetic agents) are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amasya Univessity
Amasya, Turkey (Türkiye)